Chemotherapy-induced Thrombocytopenia (CIT) in Patients With Gastrointestinal Tumors

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Chemotherapy-induced Thrombocytopenia (CIT) in Patients With Gastrointestinal Tumors trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT07492693

Efficacy and Safety of Hetrombopag in Preventing Chemotherapy-induced Thrombocytopenia in Gastrointestinal Tumors

This trial is a single-arm, prospective clinical study aimed at evaluating the efficacy and safety of hetrombopag in preventing chemotherapy-induced thrombocyto…

China40 participantsStarted 2024-10-01

Treatment: Hetrombopag

All recent trials (2 shown)

Active — Not RecruitingPhase 2

NCT05772546

Avatrombopag vs. Placebo for CIT in GI Malignancies

The purpose of this study is to compare the efficacy of two study drugs, Avatrobopag versus placebo, to treat persistent Chemotherapy-Induced Thrombocytopenia (…

United States60 participantsStarted 2023-11-01

Treatment: Avatrombopag, Matching Placebo